Chemicon Enters Gene-Targeting Agreement with Genome Biosciences | GenomeWeb

NEW YORK, Nov. 18 (GenomeWeb News) - Chemicon International, a division of Serologicals, said today that it has entered into an exclusive licensing agreement for Genome BioSciences' Positive-Positive Selection (PPS) gene-targeting technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.